Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Euro DEHP RA (risk assessment) by June?

This article was originally published in Clinica

Executive Summary

The European Union's routine risk assessment of DEHP, the softener used in PVC medical devices, could be into its final stages by early June. That is when the next sitting of the quarterly "technical meeting on existing chemicals" is held, in Arona, Italy. Member state representatives attending the last meeting, in mid-March, requested more time to review new findings on toxicity in rats, by Schilling (2002), a two-generation study in rats, and those contained in a report presented to the US Society of Toxicology meeting in Nashville on March 20. EU member states have until April 19 to put forward their final position.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT065919

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel